drugset / Trial / NCT02036554

Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

NCT02036554

Phase 4 Unknown 234 enrolled Seoul St. Mary's Hospital Novartis · collab
RandomizedParallel-groupOpen-labelPrevention

Summary

To evaluate prevention effect of combination therapy of Everolimus and low-dose Tacrolimus in comparison with standard-dose Tacrolimus therapy with Mycophenolic acid on the New Onset Diabetes Mellitus after transplantation in the renal allograft recipients

Timeline

Start
2013-03
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Everolimus Small molecule
Subject Tacrolimus Small molecule
Comparator mycophenolic acid Small molecule

Indications

No indication recorded.